Abstract

Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration

Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A

Issue: Nov/Dec 2007 - High-Technology Compounding

Page(s): 520-524

Download in electronic PDF format for $75
  • Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Page 1
  • Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Page 2
  • Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Page 3
  • Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Page 4
  • Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Page 5

Abstract

Palonosetron hydrochloride is a relatively long-acting selective 5-HT3 receptor antagonist that has been approved for the prevention of chemotherapy-induced nausea and vomiting and is being evaluated for the prevention of postoperative nausea and vomiting. The objective of this study was to evaluate the physical and chemical stability of palonosetron hydrochloride 50 mcg/mL with the b-lactam antibiotics cefazolin sodium 20 mg/mL, cefotetan disodium 20 mg/mL, and the combination ampicillin sodium–sulbactam sodium 20 mg/mL and 10 mg/mL, respectively, during simulated Y-site administration. The effects of each of the antibiotics on palonosetron hydrochloride in these admixtures were tested in triplicate. Samples were stored and evaluated for up to 4 hours at room temperature. Physical stability was assessed by turbidimetric and particulate measurements and visual inspection. Chemical stability was assessed by high-performance liquid chromatography. All of the admixtures were clear and colorless when viewed in normal fluorescent room light and when viewed with a Tyndall beam. Measured turbidity and particulate content were low initially and remained low throughout the study. The drug concentration was unchanged in all of the samples tested. Palonosetron hydrochloride is physically and chemically stable in admixtures with cefazolin sodium, cefotetan disodium, and the combination ampicillin sodium–sulbactam sodium at the concentrations tested during simulated Y-site administration over 4 hours at ambient room temperature.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2007
Pg. 520-524
Mar/Apr 2008
Pg. 156-160
Mar/Apr 2008
Pg. 170-173
Jan/Feb 2009
Pg. 78-80
Jul/Aug 2008
Pg. 368-371
Sep/Oct 2008
Pg. 460-462
Jan/Feb 2017
Pg. 76-82
May/Jun 2005
Pg. 238-241
Jul/Aug 2002
Pg. 311-315
Jul/Aug 2016
Pg. 328-332
May/Jun 2005
Pg. 235-237
Jan/Feb 2018
Pg. 76-85
May/Jun 2008
Pg. 276-278
Jan/Feb 2001
Pg. 69-73
Sep/Oct 2013
Pg. 436-438
Jan/Feb 2018
Pg. 86-94
Jan/Feb 2021
Pg. 52-61
May/Jun 2006
Pg. 234-236
May/Jun 2006
Pg. 230-233
Jan/Feb 2007
Pg. 82-85

Abstract

Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration

Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A

Issue: Nov/Dec 2007 - High-Technology Compounding

Page(s): 520-524

Download in electronic PDF format for $75
  • Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Page 1
  • Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Page 2
  • Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Page 3
  • Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Page 4
  • Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Page 5

Abstract

Palonosetron hydrochloride is a relatively long-acting selective 5-HT3 receptor antagonist that has been approved for the prevention of chemotherapy-induced nausea and vomiting and is being evaluated for the prevention of postoperative nausea and vomiting. The objective of this study was to evaluate the physical and chemical stability of palonosetron hydrochloride 50 mcg/mL with the b-lactam antibiotics cefazolin sodium 20 mg/mL, cefotetan disodium 20 mg/mL, and the combination ampicillin sodium–sulbactam sodium 20 mg/mL and 10 mg/mL, respectively, during simulated Y-site administration. The effects of each of the antibiotics on palonosetron hydrochloride in these admixtures were tested in triplicate. Samples were stored and evaluated for up to 4 hours at room temperature. Physical stability was assessed by turbidimetric and particulate measurements and visual inspection. Chemical stability was assessed by high-performance liquid chromatography. All of the admixtures were clear and colorless when viewed in normal fluorescent room light and when viewed with a Tyndall beam. Measured turbidity and particulate content were low initially and remained low throughout the study. The drug concentration was unchanged in all of the samples tested. Palonosetron hydrochloride is physically and chemically stable in admixtures with cefazolin sodium, cefotetan disodium, and the combination ampicillin sodium–sulbactam sodium at the concentrations tested during simulated Y-site administration over 4 hours at ambient room temperature.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2007
Pg. 520-524
Mar/Apr 2008
Pg. 156-160
Mar/Apr 2008
Pg. 170-173
Jan/Feb 2009
Pg. 78-80
Jul/Aug 2008
Pg. 368-371
Sep/Oct 2008
Pg. 460-462
Jan/Feb 2017
Pg. 76-82
May/Jun 2005
Pg. 238-241
Jul/Aug 2002
Pg. 311-315
Jul/Aug 2016
Pg. 328-332
May/Jun 2005
Pg. 235-237
Jan/Feb 2018
Pg. 76-85
May/Jun 2008
Pg. 276-278
Jan/Feb 2001
Pg. 69-73
Sep/Oct 2013
Pg. 436-438
Jan/Feb 2018
Pg. 86-94
Jan/Feb 2021
Pg. 52-61
May/Jun 2006
Pg. 234-236
May/Jun 2006
Pg. 230-233
Jan/Feb 2007
Pg. 82-85